Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-24T11:00:52.689Z Has data issue: false hasContentIssue false
  • English
  • Français

Serum otolin-1 as a biomarker for benign paroxysmal positional vertigo: a case-control study

Published online by Cambridge University Press:  17 June 2021

D V K Irugu ,
A Singh ,
H Yadav ,
H Verma ,
R Kumar ,
R A Abraham  and
L Ramakrishnan
D V K Irugu*
Affiliation:
Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
A Singh
Affiliation:
Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
H Yadav
Affiliation:
Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
H Verma
Affiliation:
Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
R Kumar
Affiliation:
Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
R A Abraham
Affiliation:
Department of Cardiac Biochemistry, All India Institute of Medical Sciences, New Delhi, India
L Ramakrishnan
Affiliation:
Department of Cardiac Biochemistry, All India Institute of Medical Sciences, New Delhi, India
*
Author for correspondence: Dr David Victor Kumar Irugu, Room No. 4057, ENT Office, 4th Floor, Teaching Block, All India Institute of Medical Sciences, New Delhi110029, India E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

This study aimed to evaluate serum otolin-1 levels in patients with benign paroxysmal positional vertigo and to compare these levels with healthy individuals.

Method

This was a case-control study. After obtaining institutional ethical committee clearance, the serum level of otolin-1 was calculated in adult individuals (18–75 years old) who were divided into group 1 (patients presenting with benign paroxysmal positional vertigo) and group 2 (healthy patients without benign paroxysmal positional vertigo as the control group). Data analysis was carried out to compare the serum levels in the cases and controls. A p-value less than 0.05 was considered significant.

Results

A total of 70 age-matched individuals (cases, n = 40; controls, n = 30) were included in the study. The mean serum level of otolin-1 was 636.8 pg/ml (range, 259–981 pg/ml) in the group of patients with benign paroxysmal positional vertigo and 236.2 pg/ml (range, 189–370 pg/ml) in the control group. The difference was statistically significant (p = 0.0000).

Conclusion

The serum levels of otolin-1 in patients with benign paroxysmal positional vertigo are significantly higher compared with individuals without benign paroxysmal positional vertigo.

Keywords

Benign Paroxysmal Positional VertigoBiomarkerOtolithic MembraneSemicircular Canals
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 135 , Issue 7 , July 2021 , pp. 589 - 592
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr D V K Irugu takes responsibility for the integrity of the content of the paper

References

You, P, Instrum, R, Parnes, L. Benign paroxysmal positional vertigo. Laryngoscope Investig Otolaryngol 2018;4:116–23CrossRefGoogle ScholarPubMed
Kao, WTK, Parnes, LS, Chole, RA. Otoconia and otolithic membrane fragments within the posterior semicircular canal in benign paroxysmal positional vertigo. Laryngoscope 2017;127:709–14CrossRefGoogle ScholarPubMed
Messina, A, Casani, AP, Manfrin, M, Guidetti, G. Italian survey on benign paroxysmal positional vertigo. Acta Otorhinolaryngol Ital 2017;37:328–35CrossRefGoogle ScholarPubMed
Andrade, LR, Lins, U, Farina, M, Kachar, B, Thalmann, R. Immunogold TEM of otoconin 90 and otolin - relevance to mineralization of otoconia, and pathogenesis of benign positional vertigo. Hear Res 2012;292:14–25CrossRefGoogle ScholarPubMed
Parham, K, Sacks, D, Bixby, C, Fall, P. Inner ear protein as a biomarker in circulation ? Otolaryngol Head Neck Surg 2014;151:1038–40CrossRefGoogle ScholarPubMed
Thalmann, I. Proteomics and the inner ear. Dis Markers 2001;17:259–7010.1155/2001/476738CrossRefGoogle ScholarPubMed
Hołubowicz, R, Wojtas, M, Taube, M, Kozak, M, Ozyhar, A, Dobryszycki, P. Effect of calcium ions on structure and stability of the C1q-like domain of otolin-1 from human and zebrafish. FEBS J 2017;284:4278–97CrossRefGoogle ScholarPubMed
Parham, K, Kuchel, GA, McElhaney, JE, Haynes, L. A relationship between blood levels of otolin-1 and vitamin D. Otol Neurotol 2018;39:e269–73CrossRefGoogle ScholarPubMed
Tabtabai, R, Haynes, L, Kuchel, GA, Parham, K. Age-related increase in blood levels of otolin-1 in humans. Otol Neurotol 2017;38:865–9CrossRefGoogle ScholarPubMed
Sacks, D, Parham, K. Preliminary report on the investigation of the association between BPPV and osteoporosis using biomarkers. Otol Neurotol 2015;36:1532–6CrossRefGoogle ScholarPubMed
Yang, H, Gu, H, Sun, W, Li, Y, Wu, H, Burnee, M, Zhuang, J. Estradiol deficiency is a risk factor for idiopathic benign paroxysmal positional vertigo in postmenopausal female patients. Laryngoscope 2018;128:948–53CrossRefGoogle ScholarPubMed
Doğan, M, Şahin, M, Kurtulmuş, Y. Otolin-1, as a potential marker for inner ear trauma after mastoidectomy. J Int Adv Otol 2019;15:200–310.5152/iao.2019.5155CrossRefGoogle ScholarPubMed
Sun, C, Xuan, X, Zhou, Z, Yuan, Y, Xue, F. A preliminary report on the investigation of prestin as a biomarker for idiopathic sudden sensorineural hearing loss. Ear Nose Throat J 2020;99:528–31CrossRefGoogle ScholarPubMed
Wu, Y, Han, W, Yan, W, Lu, X, Zhou, M, Li, L et al. Increased otolin-1 in serum as a potential biomarker for idiopathic benign paroxysmal positional vertigo episodes. Front Neurol 2020;11:367CrossRefGoogle ScholarPubMed
Ogun, OA, Büki, B, Cohn, ES, Janky, KL, Lundberg, YW. Menopause and benign paroxysmal positional vertigo. Menopause 2014;21:886–9CrossRefGoogle ScholarPubMed
Yu, S, Liu, F, Cheng, Z, Wang, Q. Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review. BMC Neurol 2014;14:110CrossRefGoogle ScholarPubMed
Yang, CJ, Kim, Y, Lee, HS, Park, HJ. Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo. J Vestib Res 2018;27:287–94CrossRefGoogle ScholarPubMed
Chan, KC, Tsai, YT, Yang, YH, Chen, PC, Chang, PH. Osteoporosis is associated with increased risk for benign paroxysmal positional vertigo: a nationwide population-based study. Arch Osteoporos 2017;12:106CrossRefGoogle ScholarPubMed
Lai, SW. Benign paroxysmal positional vertigo and osteoporosis. Eur Arch Otorhinolaryngol 2019;276:279CrossRefGoogle ScholarPubMed
Karatas, A, Yuceant, GA, Yuce, T, Hacı, C, Cebi, IT, Salviz, M. Association of benign paroxysmal positional vertigo with osteoporosis and vitamin D deficiency: a case-controlled study. J Int Adv Otol 2017;13:259–66CrossRefGoogle ScholarPubMed
Ding, J, Liu, L, Kong, WK, Chen, XB, Liu, X. Serum levels of 25-hydroxy vitamin D correlate with idiopathic benign paroxysmal positional vertigo. Biosci Rep 2019;39:BSR20190142CrossRefGoogle ScholarPubMed
Jeong, SH, Kim, JS, Shin, JW, Kim, S, Lee, H, Lee, AY et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol 2013;260:832–8CrossRefGoogle ScholarPubMed
Rhim, GI. Serum vitamin D and recurrent benign paroxysmal positional vertigo. Laryngoscope Investig Otolaryngol 2016;1:150–3CrossRefGoogle ScholarPubMed
AlGarni, MA, Mirza, AA, Althobaiti, AA, Al-Nemari, HH, Bakhsh, LS. Association of benign paroxysmal positional vertigo with vitamin D deficiency: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2018;275:2705–11CrossRefGoogle ScholarPubMed